206A.T

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
206A.TPRISM BioLab Co.,LTD	$160.00	-0.62%	$5.9B	—
2385.TSoiken Holdings Inc.	$219.00	+2.82%	$5.7B	—
4572.TCarna Biosciences, Inc.	$424.00	-1.85%	$8.1B	—
4576.TD. Western Therapeutics Institute, Inc.	$67.00	-2.90%	$3.9B	—
4591.TRibomic Inc.	$77.00	-2.53%	$4.3B	—
4594.TBrightPath Biotherapeutics Co., Ltd.	$57.00	-5.00%	$4.8B	—
4598.TDelta-Fly Pharma, Inc.	$109.00	-1.80%	$1.6B	—

Source: Financial Modeling Prep · peers by sector/industry

PRISM BioLab Co.,LTD

PRISM BioLab Co., LTD. engages in the research and development of pharmaceuticals using its proprietary drug discovery platform, PepMetics Technology. The company's technology focuses on creating peptide mimetic small molecules designed to mimic α-helix or β-turn peptides, which are essential for protein-protein interactions. Through its platform, PRISM aims to discover drugs for what were previously considered 'undruggable targets,' with a pipeline including candidates for cancer and fibrotic diseases.

www.prismbiolab.com

Employees: 35
IPO / List date: Jul 2, 2024
HQ: JP

Held by traders on TradeandTell

No one on the platform currently holds 206A.T.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 206A.T as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 206A.T yet.